Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 21, 2022
- Accession no.
- 0001447362-22-000201
- Filed
- Dec 21, 2022
- Trade date
- Dec 19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $206.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | Common Stock | SSaleDisposed | −1,928 | $22.73F2 | −$43,823.44 | 307,267 | Direct | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −943 | $22.73F2 | −$21,434.39 | 126,135 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −880 | $22.73F2 | −$20,002.4 | 114,844 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −189 | $22.73F2 | −$4,295.97 | 25,659 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −189 | $22.73F2 | −$4,295.97 | 25,658 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −189 | $22.73F2 | −$4,295.97 | 25,658 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −189 | $22.73F2 | −$4,295.97 | 25,654 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −1,905 | $23.41F9 | −$44,596.05 | 305,362 | Direct | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −932 | $23.41F9 | −$21,818.12 | 125,203 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −870 | $23.41F9 | −$20,366.7 | 113,974 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −186 | $23.41F9 | −$4,354.26 | 25,473 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −186 | $23.41F9 | −$4,354.26 | 25,472 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −186 | $23.41F9 | −$4,354.26 | 25,472 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −186 | $23.41F9 | −$4,354.26 | 25,468 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.090 to $23.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $23.090 to $23.865, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.